Metaculus Help: Spread the word
If you like Metaculus, tell your friends! Share this question via Facebook, Twitter, or Reddit.
When will the US FDA grant Neuralink permission to sell and implant a brain-machine interface device into general consumers?
Some text has been copied from this closely aligned question.
Neuralink Corporation is an American neurotechnology company founded in 2016 by serial entrepreneur Elon Musk and others, developing implantable brain–machine interfaces (BMIs).
Since its founding, the company has hired several high-profile neuroscientists from various universities. By July 2019, it had received $158 million in funding (of which $100 million from Musk) and was employing a staff of 90 employees.
At that time, Neuralink announced that it was working on a “sewing machine-like” robot capable of implanting very thin "threads" into the brain, demonstrated a system that read information from a lab rat's brain via thousands of electrodes (many times more than the current maximum for systems used in human brains), and Musk announced an aspirational goal to start experiments with humans in 2020, pending FDA approval.
In the short term, the company aims to develop brain-machine interfaces to assist individuals with serious physical or neurological conditions; but the longer term goal of the company is to enable human-AI symbiosis and grant superhuman cognition to anyone who wants it, as well as a form of digital immortality.
This question asks: When will the US Food and Drug Administration grant regulatory approval allowing any device developed in whole or in part by Neuralink Corporation to be sold, and implanted into the brains of human consumers?
You can find information on the FDA's Regulatory Overview for Neurological Devices here.
The implantation surgery need not actually occur by that date (or at all) in order for this question to resolve positively; this question focuses solely on when regulatory approval will be obtained.
This question resolves >2050 if no approval is given before 2050. The question resolves ambiguously if the FDA is abolished, or if its role is changed such that regulatory approval is no longer required for this procedure.
2020-08-17 : removed § triggering positive resolution upon Investigational Device Exemption or Humanitarian Device Exemption. See this thread.
Metaculus help: Predicting
Predictions are the heart of Metaculus. Predicting is how you contribute to the wisdom of the crowd, and how you earn points and build up your personal Metaculus track record.
The basics of predicting are very simple: move the slider to best match the likelihood of the outcome, and click predict. You can predict as often as you want, and you're encouraged to change your mind when new information becomes available.
The displayed score is split into current points and total points. Current points show how much your prediction is worth now, whereas total points show the combined worth of all of your predictions over the lifetime of the question. The scoring details are available on the FAQ.
Note: this question resolved before its original close time. All of your predictions came after the resolution, so you did not gain (or lose) any points for it.
Note: this question resolved before its original close time. You earned points up until the question resolution, but not afterwards.
This question is not yet open for predictions.
Metaculus help: Community Stats
Use the community stats to get a better sense of the community consensus (or lack thereof) for this question. Sometimes people have wildly different ideas about the likely outcomes, and sometimes people are in close agreement. There are even times when the community seems very certain of uncertainty, like when everyone agrees that event is only 50% likely to happen.
When you make a prediction, check the community stats to see where you land. If your prediction is an outlier, might there be something you're overlooking that others have seen? Or do you have special insight that others are lacking? Either way, it might be a good idea to join the discussion in the comments.